TRIM-NET A training network in drug discovery targeting TRIM ubiquitin ligases

The Project

TRIM proteins are involved in many diseases and clinically relevant processes emphasizing the need for deep knowledge of TRIM proteins mechanism of action in order to design and develop targeting strategies. The ultimate goal of TRIM-NET is determining how TRIM proteins contribute to disease and how we can use this information to develop novel therapeutics for TRIM family members that are involved in common and rare pathologies, thus heavily impacting on public health.

Read more >>

Marie Skłodowska-Curie Action - Innovative Training Networks

Starting date: January 1, 2019
Closing date: December 31, 2022

This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement No 813599, call H2020-MSCA-ITN-2018 - Innovative Training Networks 2018.

Latest news

news
meetings
activities
16 Sep 2021 - 17 Sep 2021
Schwarzwald Panorama, Bad Herrenalb, Germany

TRIM-NET Research Groups

KIT - Karlsruher Institut fuer Technologie
D
Christine BLATTNER
INRA - Institut National de la Recherche Agronomique
FR
Daniel TAILLANDIER
CSS-IRCCS - Fondazione Casa Sollievo della Sofferenza
IT
Giuseppe MERLA
NKI-AVL - Nederlands Kanker Instituut-Antoni van Leeuwenhoek
NL
Wilbert ZWART

TRIM-NET Partners Organisations

PMF - PharmaTrain Federation
B
Heinrich KLECH
UG - Ubiquigent Ltd
UK
Jason BROWN
Genomics and Epigenomics Laboratory – Area Science Park
IT
Danilo LICASTRO PhD
LABCYTE ltd.
UK
Carl JARMAN
OcellO B.V.
NL
Leo PRICE